About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 407 record(s)
Req # A-2023-025211
With regard to the c. 2003 HDAP Report on New Patented Drug - Angiomax (http://www.pmprbcepmb.gc.ca/view.asp?ccid=583), I am looking for a copy of any supporting research, reports and calculations used to determine dosage regimens. I am specifically interested in how these quantities (in mL) were derived, the benchmark patient weight that was used (in kg) and the timeframe of the dosing.Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-025599
For FY 2015-2022 (inclusive), how many investigations into prescription pricing on the basis that the pricing exceeded the guidelines resulted in a public hearing? Of those that resulted in a public hearing, in how many was the pricing found to be excessive? Of those that were found to be excessive, how many resulted in orders to reduce the prescription price?Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-025896
For fiscal years 2015-2022 (inclusive), how many new patented medicines were reported to the board by Bayer, Inc.? From among those reports, how many included claims that a price exceeded the guidelines?Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-025600
For FY 2015-2022 (inclusive), how many Advance Certificate Rulings were issued by the board?Organization: Patented Medicine Prices Review Board Canada
July 2023
Req # A-2023-00008
Provide the following briefing documents prepared in March 2023: BN0014961 Launch Site ComparisonOrganization: Canadian Space Agency
June 2023
Req # A-2023-00009
Provide the following briefing documents prepared in April 2023: BN0015420 Planet Labs.Organization: Canadian Space Agency
June 2023
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2023-00002
Provide 2022, 2023 briefings, memos on costs of training astronauts, past, present, future. Date range: January 1, 2022 to May 2, 2023 CLARIFICATION : Canadian astronauts onlyOrganization: Canadian Space Agency
May 2023
Req # A-2023-00003
Provide 2022, 2023 briefings, memos on assessments of Canadian space launch sites. Date range: January 1, 2022 to May 2, 2023Organization: Canadian Space Agency
May 2023
Req # A-2023-00007
Provide 2022, 2023 briefings, memos on current strategies to deal with space debris, asteroids. Date range: January 1, 2022 to May 2, 2023Organization: Canadian Space Agency
May 2023